12 Channel Electrocardiograph Market Size & Share, by End User (Hospitals, Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions); Product Type; Technology; Lead Configuration; Application - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

12 Channel Electrocardiograph Industry - Regional Synopsis

North America Market Analysis

North American market is poised to hold the largest share of 39.6% by the end of 2037. This growth is fueled by the surge in healthcare spending, rising incidence of heart failures, and rapid implementation of cutting-edge ECG technologies. Also, the population and health providers in the region are aware of the benefits pertaining to ECG devices. Few devices such as continuous ECG monitoring systems, electronic wrist watches, and handheld and portable ECG devices are readily available in the region, thereby boosting the market.

The 12 channel electrocardiograph market in the U.S. is bolstering based on the availability of devices that are approved by regulatory organizations. For instance, in June 2024, Tempus AI, Inc. received the 510(k) clearance from the U.S. FDA for its Tempus ECG-AF device. The objective of the device is to utilize artificial intelligence to assist in identifying patients with an increased risk of atrial fibrillation or flutter (AF). This was the first clearance for an AF indication in the cardiovascular machine learning-based statement software and which paved the way for physicians to implement this ground-breaking algorithm in the care of patients.

The 12 channel electrocardiograph market in Canada is gaining increasing exposure owing to financial contributions initiated by the government. For instance, as per the May 2022 Government of Canada report, the Parliament Secretary, on behalf of the Health Minister, proclaimed an investment of USD 5 million. The purpose was to reinforce the latest national research network that will put emphasis on enlightening the inhibition, diagnosis, treatment, and care of heart failure across the country, thus suitable for the market evolution.

APAC Market Statistics

Asia Pacific is expected to derive as the fastest-growing region in the global market during the forecast timeline. There is continuous growth in the monitoring and diagnosis of heart health in the region, since there is a growing emphasis on the occurrence of cardiac issues. The population in China is more prone to being severely affected by ECG abnormalities in comparison to the South Asia population. Besides, the overall region is projected to comprise ECG-detected left ventricular hypertrophy (LVH), which effectively drives the market development.

The market in India is deliberately present in urban areas with its increased availability in regional hospitals. As mentioned in the December 2021 NLM article, the District Health Authority in Ahmedabad unveiled Project Lifeline, which comprised the provision of 12-lead portable ECG devices across all main healthcare centers. These devices can save lives for up to 2.9 years at INR 6657.47 (USD 89.97) and a cost-effective ratio of INR 2,299.06 (USD 31.07). Therefore, this project is operating successfully and is suitable for symptomatic and high-risk cases, thus enhancing the market demand in the country.

The 12 channel electrocardiograph market in China is experiencing effective growth owing to its increased utilization and demand. According to a clinical study published by NLM in September 2020, 34,965 patients from the country were considered to detect the ECG abnormalities factors. It was found that 1.04%, 1.70%, and 2.37% of the total patient pool, including both men and women, suffered from major arrhythmias. Besides, among 0.20% of women and 0.35% of men, atrial fibrillation was demonstrated to be quite common. Also, T abnormalities and ST depression were prevalent among 7.54%, 10.96%, and 14.32%, thus driving the demand of the market in the country.